Nicole Germino
Stock Analyst at Truist Securities
(0.14)
# 3,479
Out of 4,415 analysts
12
Total ratings
25%
Success rate
-41.5%
Average return
Main Sectors:
Top Industries:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Initiates: Buy | $48 | $25.55 | +87.87% | 1 | Apr 23, 2024 | |
| FUSN Fusion Pharmaceuticals | Downgrades: Hold | $11 → $21 | $21.45 | -2.10% | 3 | Mar 20, 2024 | |
| SGMO Sangamo Therapeutics | Downgrades: Hold | n/a | $0.56 | - | 4 | Nov 7, 2023 | |
| ASMB Assembly Biosciences | Downgrades: Hold | $132 → $24 | $13.15 | +82.51% | 3 | Oct 24, 2022 | |
| FBRX Forte Biosciences | Downgrades: Hold | n/a | $0.71 | - | 1 | Sep 3, 2021 |
Insmed
Apr 23, 2024
Initiates: Buy
Price Target: $48
Current: $25.55
Upside: +87.87%
Fusion Pharmaceuticals
Mar 20, 2024
Downgrades: Hold
Price Target: $11 → $21
Current: $21.45
Upside: -2.10%
Sangamo Therapeutics
Nov 7, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.56
Upside: -
Assembly Biosciences
Oct 24, 2022
Downgrades: Hold
Price Target: $132 → $24
Current: $13.15
Upside: +82.51%
Forte Biosciences
Sep 3, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.71
Upside: -